Global Markets Direct’s, ‘Promius Pharma, LLC - Product Pipeline Review - 2016’, provides an overview of the Promius Pharma, LLC’s pharmaceutical research and development focus.
The report provides comprehensive information on the therapeutics under development by Promius Pharma, LLC, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.
- The report provides a snapshot of the pipeline therapeutic landscape of Promius Pharma, LLC - The report provides overview of Promius Pharma, LLC including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Promius Pharma, LLC’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Promius Pharma, LLC’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
- Evaluate Promius Pharma, LLC’s strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Promius Pharma, LLC - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Promius Pharma, LLC’s pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Our reports have been used by over 10K customers, including:
“UBLITUXIMAB + UMBRALISIB - Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Diffuse Large B-Cell Lymphoma in 7 Major Markets. A detailed picture of the UBLITUXIMAB + UMBRALISIB in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the...
“BIIB059 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Cutaneous Lupus Erythematosus in 7 Major Markets. A detailed picture of the BIIB059 in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for...
“UniCAR02-T-CD123 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Blastic Plasmacytoid Dendritic Cell Neoplasm in 7 Major Markets. A detailed picture of the UniCAR02-T-CD123 in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the...
“AD128 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Obstructive sleep Apnea in 7 Major Markets. A detailed picture of the AD128 in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study...
300 pages •
By The Business Research Company
• Feb 2021
Major companies in the scientific research and development services market include Battelle Memorial Institute; IQVIA Holdings Inc; Defense Advanced Research Projects Agency; Lawrence Livermore National Laboratory LLC and Los Alamos National Laboratory. The global scientific research and development services market is expected to grow...
2021 Leading Automotive Companies SWOT Analysis--Capabilities, Goals and Strategies
This report is part of the Competitive Analysis Series prepared to help current suppliers and potential market entrants realistically assess their financial, technological and marketing capabilities in relation to the leading competitors.
120 pages •
By Infiniti Research Limited
• Jan 2021
Global Portable Ultrasound Equipment Market 2021-2025
The analyst has been monitoring the portable ultrasound equipment market and it is poised to grow by $ 1.58 bn during 2021-2025 progressing at a CAGR of 13% during the forecast period. Our report on portable ultrasound equipment market provides a holistic analysis,...
What’s Driving the Biotechnology Industry?--The Road to 2025 and Beyond This report is available by section, and can be customized to specific objectives, information needs and budget. The series includes current assessments of more than 1,000 companies worldwide. Depending on the company’s business nature and structure,...
The high speed connector market was valued at US$ 3,037.65 million in 2019 and is projected to reach US$ 5,658.42 million by 2027; it is expected to grow at a CAGR of 8.3% from 2020 to 2027. Growing investments by government as well as private and public companies in strengthening their communication infrastructure for global market reach...
Aerospace And Defense
Research And Development
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.